Reform

f9a57bfe-51c7-11e9-8939-5623721d3707

Europe’s pragmatic approach to clinical evidence for legacy devices – or why the devil is always in the detail…

By Arthur Brandwood | 30 March 2019
Regulatory affairs demand attention to detail. So when the European Medical Devices Coordination Group released document MDCG 2019-3 - Interpretation of Article 54(2)b we regulatory geeks just knew we should...
shutterstock_708015040

NZ Makes it Formal – Medical Devices Reform in The Land of the Long White Cloud

By Arthur Brandwood | 28 March 2019
New Zealand has always been a relaxed sort of place – and that included the regulation of medical devices which up till now has been limited to a simple notification...
Sauce

China update – regulation with a European sauce?

By Arthur Brandwood | 7 August 2018
CFDA continues to propose more changes to medical device regulation, and as ever the agency looks to international practices and seeks to weave them in to China requirements. A recent...

Search

Recent Posts

Provisionally yours

Jan 27, 2021

Clinical Evidence Insights for Medical Devices in China

Jan 22, 2021

EUDAMED is LIVE

Dec 15, 2020

MD Regulatory transition under Brexit

Dec 15, 2020

DOC’s will need to be submitted for new Class I IVD ARTG registrations

Nov 26, 2020

Formulated ingredients and premixes: Keeping the IP of a PI

Nov 24, 2020

Categories

Categories

Archives

Archives

Archives

Tags

510(k) ARTG Australia Biocompatibility Brexit CE CE Certificates China clinical evidence clinical trials Conformity Assessment coronavirus COVID-19 COVID19 de novo Drug EU Europe FDA guidance IVD IVDD IVDR IVDs MDD MDR MDSAP medical device Medical Device Regulations medical devices Medicine medicines MHRA Pharmaceutical PMA PMDA postmarket Reform regulatory Reimbursement SaMD Software Software as a Medical Device (SaMD) standards TGA